Strategic partnerships NantWorks has demonstrated active collaboration with large health and biotech ecosystems, including ImmunityBio and participation in international biotech summits (US-Saudi Biotech Alliance). This presents a sales opportunity to offer complementary platforms, shared R&D services, and co-development partnerships for translational research and manufacturing scale-up.

Scaleable manufacturing Past investments in vaccine and cell-based therapy manufacturing capacity and a goal to produce billions of vaccines indicate a strong appetite for large-scale production capabilities, process optimization, and contract manufacturing services that we could align with for scalable biotech solutions.

AI and analytics NantWorks operates in biotech and healthcare AI and utilizes tools like JMP, LabVIEW, and analytics platforms. There is an opportunity to offer data integration, AI-driven discovery, and workflow optimization solutions that accelerate research timelines and improve decision quality across their portfolio.

Emerging platforms With a network spanning NantHealth, ImmunityBio, and cancer vaccines, NantKwest and related entities, there is potential to cross-sell specialized research tools, diagnostic integrations, and regulatory-compliant manufacturing tech to support vaccine and immunotherapy programs.

International expansion Participation in global health initiatives and the US-Saudi summit signals readiness for cross-border partnerships and technology transfer. A sales strategy could target international collaboration, licensing, and joint ventures to support global distribution and manufacturing footprint.